Petenkaya, A. Et Al. 2006. Lack of association between the MDM2-SNP309 polymorphism and breast cancer risk. ANTICANCER RESEARCH , vol.26, no.6C , 4975-4977.

Petenkaya, A., Bozkurt, B., Akilli-Ozturk, O., Kaya, H. S., Gur-Dedeoglu, B., & Yulug, I. G., (2006). Lack of association between the MDM2-SNP309 polymorphism and breast cancer risk. ANTICANCER RESEARCH , vol.26, no.6C, 4975-4977.

Petenkaya, Aslihan Et Al. "Lack of association between the MDM2-SNP309 polymorphism and breast cancer risk," ANTICANCER RESEARCH , vol.26, no.6C, 4975-4977, 2006

Petenkaya, Aslihan Et Al. "Lack of association between the MDM2-SNP309 polymorphism and breast cancer risk." ANTICANCER RESEARCH , vol.26, no.6C, pp.4975-4977, 2006

Petenkaya, A. Et Al. (2006) . "Lack of association between the MDM2-SNP309 polymorphism and breast cancer risk." ANTICANCER RESEARCH , vol.26, no.6C, pp.4975-4977.

@article{article, author={Aslihan Petenkaya Et Al. }, title={Lack of association between the MDM2-SNP309 polymorphism and breast cancer risk}, journal={ANTICANCER RESEARCH}, year=2006, pages={4975-4977} }